Innovative Genetics

Innovative Genetics is building the infrastructure layer powering the next generation of compliant therapeutics. We develop and license BioIP—fast-acting formulations, nationally trademarked brand systems, compliant packaging, and deployable production infrastructure—designed for scalability, protected by IP, and structured for recurring revenue. Our model is entirely non-substance-touching. We do not manufacture, cultivate, or distribute active ingredients. Instead, we enable vetted operators in legal U.S. markets to commercialize faster, safer, and at lower operational risk—without federal exposure or capital-heavy overhead. With a projected $95B+ addressable market by 2032 across functional therapeutics and psychoactive wellness, we help power what’s next.